Diabetic macular edema (DME) is a very important and well-known cause of visual loss in
diabetics. Blood–retina barrier disruption and consequent intraretinal fluid accumulation …

Abstract Purpose of Review Diabetic retinopathy (DR) is the leading cause of vision loss in
working-age adults in the developed world. This review discusses the current approach to …

The integrity of retinal ganglion cells is tightly associated with diabetic macular degeneration
that leads to damage and death of retinal ganglion cells, affecting vision. The major clinical …

Background Diabetic macular edema (DME) is an important cause of vision loss and despite
the anatomical and functional improvement achieved with treatment, there are reports of …

Background To evaluate functional and anatomical consequences of switching anti-vascular
endothelial growth factor (anti-VEGF) therapy from bevacizumab and/or ranibizumab to …

The high prevalence of Diabetic macular edema (DME) is a real global health problem. Its
complex pathophysiology involves different pathways. Over the last decade, the introduction …

Purpose To quantify inflammatory, growth/angiogenic, and tissue remodeling mediators in
vitreal reflux (VR) in patients with diabetic macular edema (DME), as collected at first and …

Intraocular anti-vascular endothelial growth factor (VEGF) therapies are the front-line
treatment for diabetic macular edema (DME); however, treatment response varies widely …

Vascular contributions to cognitive impairment and dementia (VCID) is one of the leading
causes of dementia along with Alzheimer's disease (AD) and, importantly, VCID often …

Diabetic retinopathy (DR) is an important complication with a high incidence of 34.6% in the
diabetic populations. DR could finally lead to vision impairment without effective …